Cassava Sciences, Inc.
Cassava Sciences, Inc. (SAVA) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · SAVA · as of Sep 30, 2025
Ownership Breakdown
116
Institutional Holders
▲ 2 vs Q2
$40.07M
Total Inst. Value
▲ $17.86M vs Q2
48.31M
Shares Outstanding
freeFloat 88.98%
13.78M
13F Shares Held
▲ 1.52M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
SAVA largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC pharmaceutical preparations | 2.29M | 4.74% | 4.74% | $6.66B | Nov 7, 2025 | ▲ 119.5K |
MARSHALL WACE, LLP pharmaceutical preparations | 2.06M | 4.27% | 4.27% | $6.00B | Nov 13, 2025 | ▲ 1.99M |
BLACKROCK, INC. pharmaceutical preparations | 1.41M | 2.92% | 2.92% | $4.10B | Nov 12, 2025 | ▼ 136.8K |
TWO SIGMA ADVISERS, LP pharmaceutical preparations | 961.5K | 1.99% | 1.99% | $2.80B | Nov 14, 2025 | ▼ 22.1K |
JPMORGAN CHASE & CO pharmaceutical preparations | 565.4K | 1.17% | 1.17% | $1.65B | Nov 26, 2025 | ▼ 191.6K |
TWO SIGMA INVESTMENTS, LP pharmaceutical preparations | 565.0K | 1.17% | 1.17% | $1.64B | Nov 14, 2025 | ▲ 38.5K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 537.9K | 1.11% | 1.11% | $1.57B | Nov 12, 2025 | ▲ 15.0K |
GOLDMAN SACHS GROUP INC pharmaceutical preparations | 472.9K | 97.88% | 97.88% | $1.38B | Nov 14, 2025 | ▼ 140.3K |
GMT CAPITAL CORP pharmaceutical preparations | 450.1K | 93.17% | 93.17% | $1.31B | Nov 14, 2025 | — held |
683 CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 425.0K | 87.98% | 87.98% | $1.24B | Nov 14, 2025 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
19
Increased
+2.96M shares8
New Positions
first time holders18
Decreased
−1.49M shares0
Sold Out
fully exitedNet shares change (top 50)
+1.46M
+2.96M / −1.49M
Net new holders
+9
8 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
SAVA insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
4
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Anderson Robert Eugene Jr director | Nov 24, 2025 | Purchase | 8,600 | $2.90 | $24.9K | 8.6K | Form 4 ↗ |
Barry Richard President & CEO | Nov 20, 2025 | Purchase | 150,000 | $2.76 | $414.0K | 938.1K | Form 4 ↗ |
Barry Richard President & CEO | Nov 19, 2025 | Purchase | 73,385 | $2.75 | $201.8K | 788.1K | Form 4 ↗ |
Bir Dawn Carter director | Oct 21, 2025 | Award | 53,000 | $3.98 | $210.9K | 53.0K | Form 4 ↗ |
Cook Robert Christopher Chief Operating & Legal Office | Sep 30, 2025 | Purchase | 13,725 | $2.91 | $39.9K | 13.7K | Form 4 ↗ |
Barry Richard President & CEO | Sep 22, 2025 | Purchase | 7,172 | $2.28 | $16.4K | 714.7K | Form 4 ↗ |
Barry Richard President & CEO | Sep 19, 2025 | Purchase | 46,908 | $2.29 | $107.4K | 707.5K | Form 4 ↗ |
Barry Richard President & CEO | Sep 19, 2025 | Purchase | 400 | $2.25 | $900 | 660.6K | Form 4 ↗ |
Barry Richard President & CEO | Sep 18, 2025 | Purchase | 185,233 | $2.24 | $414.9K | 660.2K | Form 4 ↗ |
Barry Richard President & CEO | Sep 18, 2025 | Purchase | 5,400 | $2.13 | $11.5K | 475.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Cassava Sciences, Inc. (SAVA) is primarily owned by institutional investors, who hold approximately 28.5% of total shares outstanding. Company insiders own approximately 11.02%, while retail and public investors account for the remaining 60.46%.
The largest institutional shareholder of Cassava Sciences, Inc. is VANGUARD GROUP INC, holding approximately 2.29 million shares — equal to 4.74% of outstanding shares — as of September 30, 2025.
A total of 116 institutional investors currently hold SAVA stock, with a combined institutional value of approximately $40,074,446 as of the most recent 13F filing period.
Frequently asked questions
SAVA ownershipCassava Sciences, Inc. (SAVA) is primarily owned by institutional investors, who hold approximately 28.5% of shares. The largest shareholder is VANGUARD GROUP INC with a 4.74% stake. Company insiders hold 11.02%. Data sourced from SEC Form 13F as of September 30, 2025.